Structural Basis of the Change in the Interaction Between Mycophenolic Acid and Subdomain IIA of Human Serum Albumin During Renal Failure

Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural–Chemical Investigation

(2022) Kenshiro Hirata et al.   ACS Omega

Interaction of Benzbromarone with Subdomains IIIA and IB/IIA on Human Serum Albumin as the Primary and Secondary Binding Regions

(2021) Keishi Yamasaki et al.   MOLECULAR PHARMACEUTICS

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

(2019) Dorothee Liebschner et al.   Acta Crystallographica Section D-Structural Biology

A combined photophysical and computational study on the binding of mycophenolate mofetil and its major metabolite to transport proteins

(2018) Victoria Vendrell-Criado et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

MolProbity: More and better reference data for improved all-atom structure validation

(2017) Christopher J. Williams et al.   PROTEIN SCIENCE

Improvements to the APBS biomolecular solvation software suite

(2017) Elizabeth Jurrus et al.   PROTEIN SCIENCE

Spectroscopy study and co-administration effect on the interaction of mycophenolic acid and human serum albumin

(2015) Xiaoli Ma et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases

(2014) Kohei Nagumo et al.   PLoS One

Correspondence of Fatty Acid and Drug Binding Sites on Human Serum Albumin: A Two-Dimensional Nuclear Magnetic Resonance Study

(2013) Eileen S. Krenzel et al.   BIOCHEMISTRY

Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin–ligand complexes

(2013) Ulrich Kragh-Hansen   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Albumin–drug interaction and its clinical implication

(2013) Keishi Yamasaki et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease

(2013) Azrin N. Abd Rahman et al.   CLINICAL PHARMACOKINETICS

Subdomain IB Is the Third Major Drug Binding Region of Human Serum Albumin: Toward the Three-Sites Model

(2013) Ferenc Zsila   MOLECULAR PHARMACEUTICS

Towards automated crystallographic structure refinement withphenix.refine

(2012) Pavel V. Afonine et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

REFMAC5 for the refinement of macromolecular crystal structures

(2011) Garib N. Murshudov et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Overview of theCCP4 suite and current developments

(2011) Martyn D. Winn et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins

(2011) Hiroshi Watanabe et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

XDS

(2010) Wolfgang Kabsch   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Features and development ofCoot

(2010) P. Emsley et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Molecular replacement withMOLREP

(2009) Alexei Vagin et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Pharmacokinetic Modelling of the Plasma Protein Binding of Mycophenolic Acid in Renal Transplant Recipients

(2009) Reinier M. van Hest et al.   CLINICAL PHARMACOKINETICS

Lessons from the Crystallographic Analysis of Small Molecule Binding to Human Serum Albumin

(2009) Stephen Curry   Drug Metabolism and Pharmacokinetics